These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2271370)

  • 1. End-stage renal disease and non-narcotic analgesics: a case-control study.
    Morlans M; Laporte JR; Vidal X; Cabeza D; Stolley PD
    Br J Clin Pharmacol; 1990 Nov; 30(5):717-23. PubMed ID: 2271370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesics use and ESRD in younger age: a case-control study.
    van der Woude FJ; Heinemann LA; Graf H; Lewis M; Moehner S; Assmann A; Kühl-Habich D
    BMC Nephrol; 2007 Dec; 8():15. PubMed ID: 18053232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Habitual use of acetaminophen as a risk factor for chronic renal failure: a comparison with phenacetin.
    Buckalew VM
    Am J Kidney Dis; 1996 Jul; 28(1 Suppl 1):S7-13. PubMed ID: 8669433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.
    Michielsen P; Heinemann L; Mihatsch M; Schnülle P; Graf H; Koch KM
    Nephrol Dial Transplant; 2009 Apr; 24(4):1253-9. PubMed ID: 19037086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease.
    Ibáñez L; Morlans M; Vidal X; Martínez MJ; Laporte JR
    Kidney Int; 2005 Jun; 67(6):2393-8. PubMed ID: 15882284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic renal failure and end-stage renal disease in northwest North Carolina. Importance of analgesic-associated nephropathy.
    Gonwa TA; Hamilton RW; Buckalew VM
    Arch Intern Med; 1981 Mar; 141(4):462-5. PubMed ID: 7212889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic study of regular analgesic use and end-stage renal disease.
    Murray TG; Stolley PD; Anthony JC; Schinnar R; Hepler-Smith E; Jeffreys JL
    Arch Intern Med; 1983 Sep; 143(9):1687-93. PubMed ID: 6615090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis.
    Stewart JH; Hobbs JB; McCredie MR
    Cancer; 1999 Oct; 86(8):1576-82. PubMed ID: 10526288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic use and chronic renal disease.
    Sandler DP; Smith JC; Weinberg CR; Buckalew VM; Dennis VW; Blythe WB; Burgess WP
    N Engl J Med; 1989 May; 320(19):1238-43. PubMed ID: 2651928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of analgesics and risk of renal cell cancer.
    Chow WH; McLaughlin JK; Linet MS; Niwa S; Mandel JS
    Int J Cancer; 1994 Nov; 59(4):467-70. PubMed ID: 7960214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International renal-cell cancer study. II. Analgesics.
    McCredie M; Pommer W; McLaughlin JK; Stewart JH; Lindblad P; Mandel JS; Mellemgaard A; Schlehofer B; Niwa S
    Int J Cancer; 1995 Jan; 60(3):345-9. PubMed ID: 7829242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic use of analgesics].
    Bronder E; Klimpel A; Pommer W; Molzahn M
    Soz Praventivmed; 1990; 35(4-5):147-51. PubMed ID: 2238838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesics and the kidney.
    Br Med J; 1973 Jul; 3(5872):123-4. PubMed ID: 4720760
    [No Abstract]   [Full Text] [Related]  

  • 14. Analgesic use and chronic renal failure: a critical review of the epidemiologic literature.
    McLaughlin JK; Lipworth L; Chow WH; Blot WJ
    Kidney Int; 1998 Sep; 54(3):679-86. PubMed ID: 9734593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regular use of analgesics is a risk factor for renal cell carcinoma.
    Gago-Dominguez M; Yuan JM; Castelao JE; Ross RK; Yu MC
    Br J Cancer; 1999 Oct; 81(3):542-8. PubMed ID: 10507783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: analgesic nephropathy: a soda and a powder.
    Appel RG; Bleyer AJ; McCabe JC
    Am J Med Sci; 1995 Oct; 310(4):161-6. PubMed ID: 7573121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational and other exposures associated with male end-stage renal disease: a case/control study.
    Steenland NK; Thun MJ; Ferguson CW; Port FK
    Am J Public Health; 1990 Feb; 80(2):153-7. PubMed ID: 2153349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regular analgesic intake and the risk of end-stage renal failure.
    Pommer W; Bronder E; Greiser E; Helmert U; Jesdinsky HJ; Klimpel A; Borner K; Molzahn M
    Am J Nephrol; 1989; 9(5):403-12. PubMed ID: 2801788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulations controlling the sale of mild analgesics in Canada.
    Bishop J; Znamirowska MI; Meltzer AS
    Can Med Assoc J; 1972 Oct; 107(8):758 passim. PubMed ID: 4638852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends of analgesic nephropathy in two high-endemic regions with different legislation.
    Michielsen P; Schepper P
    J Am Soc Nephrol; 2001 Mar; 12(3):550-556. PubMed ID: 11181803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.